Vicore and Alex Therapeutics will seek to advance Almee™ in partnership with the developers of approved and late-stage molecular therapies for the treatment of pulmonary fibrosis.
For more information please contact:
info@vicorepharma.com
If you are a patient and would like to ask about Almee™, please write to: almee@alextherapeutics.com.